Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPL-01 for postoperative analgesia after open inguinal hernia repair
CTR20231776Phase 3Completed
- Sponsor
- Jiali Biotechnology
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of CPL-01 in postoperative pain (3 arms), sponsored by Jiali Biotechnology. Primary endpoint: Mean AUC of activity numeric rating scale pain score over 72 hours (CPL-01 vs placebo, wWOCF-adjusted). Started Jun 2023; status: completed.
02
Drugs
CPL-01
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20231776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231776.